Use of IFN-γ and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases

Raquel Villar-Hernández, Irene Latorre, Sonia Mínguez, Jéssica Díaz, Esther García-García, Beatriz Muriel-Moreno, Alicia Lacoma, Cristina Prat, Alex Olivé, Morten Ruhwald, Lourdes Mateo, José Domínguez

    Research output: Contribution to journalArticleResearchpeer-review

    8 Citations (Scopus)

    Abstract

    © 2017 The British Infection Association Objectives Biologic agents are used against rheumatic diseases, however, they increase the risk of developing severe infections and diseases such as tuberculosis. We aimed to determine the benefits of IP-10 detection to diagnose latent tuberculosis infection (LTBI) in patients with inflammatory rheumatic diseases on different immunosuppressive drug regimens, and compare these results with IFN-γ detection. Materials and methods We included 64 patients with inflammatory rheumatic diseases. We used QuantiFERON Gold In-Tube (QFN-G-IT) and T-SPOT.TB to detect IFN-γ production, and an in-house ELISA for IP-10 detection from the previous QFN-G-IT stimulated samples. We assessed the combined use of IFN-γ release assays (IGRAs) and IP-10 test, and analyzed the influence of immunotherapy on the tests performance. Results We obtained 34.9% positive results by T-SPOT.TB, 25.0% by QFN-G-IT and 31.3% by IP-10 test. The combined use of IGRAs and IP-10 detection increased significantly the amount of positive results (p < 0.0001). Treatment intake had no significant effect on in vitro tests (p > 0.05). Conclusions IP-10 and IFN-γ detection is comparable and their combined use could increase the number of positive results in the diagnosis of LTBI in rheumatic patients. The tested assays were not influenced by rheumatoid immunosuppressive therapy. Thus, IP-10 could be of use in the development of new and improved LTBI diagnostic tools.
    Original languageEnglish
    Pages (from-to)315-325
    JournalJournal of Infection
    Volume75
    Issue number4
    DOIs
    Publication statusPublished - 1 Oct 2017

    Keywords

    • IGRAs
    • IP-10
    • Inflammatory rheumatic diseases
    • QuantiFERON
    • T-SPOT.TB
    • Tuberculosis infection

    Fingerprint

    Dive into the research topics of 'Use of IFN-γ and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases'. Together they form a unique fingerprint.

    Cite this